Seasonal variation of diclofenac concentration and its relation with wastewater characteristics at two municipal wastewater treatment plants in Turkey

Journal of Hazardous Materials

Volumn 272, Issue , 2014, Pages 155-164

  Sari, Sevgi ^a   Ozdemir, Gamze ^a   Yangin Gomec, Cigdem ^a   Zengin, Gulsum Emel ^a   Topuz, Emel ^a   Aydin, Egemen ^a   Pehlivanoglu Mantas, Elif ^a   Okutman Tas, Didem ^a  

^a ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Conventional parameters; Micropollutants; Municipal wastewater treatment; Pharmaceutical compound; Priority pollutant

Indexed keywords

DISINFECTION; EFFICIENCY; EFFLUENTS; NITROGEN REMOVAL; RECLAMATION; SEWAGE PUMPING PLANTS; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

CONVENTIONAL PARAMETERS; MICROPOLLUTANTS; MUNICIPAL WASTEWATER TREATMENT; PHARMACEUTICAL COMPOUNDS; PRIORITY POLLUTANTS;

SEWAGE TREATMENT PLANTS;

DICLOFENAC; NITROGEN; WASTE WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; POLLUTANT REMOVAL; SEASONAL VARIATION; SEWAGE TREATMENT; SUSPENDED LOAD; WASTEWATER;

ACTIVATED SLUDGE; ARTICLE; BIOTRANSFORMATION; CHEMICAL OXYGEN DEMAND; CHLORINATION; DISINFECTION; NITRIFICATION; OXIDATION; OZONATION; SEASONAL VARIATION; SEDIMENTATION; SUSPENDED PARTICULATE MATTER; TOTAL ORGANIC CARBON; TURKEY (REPUBLIC); ULTRAVIOLET RADIATION; WASTE WATER MANAGEMENT; CHEMISTRY; PROCEDURES; SEASON; SEWAGE; TURKEY; WASTE WATER; WATER MANAGEMENT; WATER POLLUTANT;

TURKEY;

DICLOFENAC; NITROGEN; SEASONS; TURKEY; ULTRAVIOLET RAYS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

EID: 84897440085     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2014.03.015     Document Type: Article

References (52)

1. Daughton C.G. Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environ. Health Perspect. 2003, 111:775-785.
2. Kuemmerer K. Pharmaceuticals in the environment. Annu. Rev. Environ. Resour. 2010, 35:57-75.
3. Jelic A., Gros M., Ginebreda A., Cespedes-Sanchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1165-1176.
4. Yamashita N., Yasojima M., Nakada N., Miyajima K., Komori K., Suzuki Y., Tanaka H. Effects of antibacterial agents, levofloxacin and clarithromycin, on aquatic organisms. Water Sci. Technol. 2006, 53:65-72.
5. Sanderson H., Johnson D.J., Wilson C.J., Brain R.A., Solomon K.R. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol. Lett. 2003, 144:383-395.
6. Kreuzinger N., Clara M., Strenn B., Vogel B. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater. Water Sci. Technol 2004, 50:221-228.
7. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 2005, 39:97-106.
8. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40:357-363.
9. Radjenovic J., Petrovic M., Barceló D. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal. Bioanal. Chem. 2007, 387:1365-1377.
10. Suarez S., Lema J.M., Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res. 2010, 44:3214-3224.
11. Wu C., Spongberg A.L., Witter J.D. Use of solid phase extraction and liquid chromatography-tandem mass spectrometry for simultaneous determination of various pharmaceuticals in surface water. Int. J. Environ. Anal. Chem. 2008, 88:1033-1048.
12. Sun Z., Schussler W., Sengl M., Niessner R., Knopp D. Selective trace analysis of diclofenac in surface and wastewater samples using solid-phase extraction with a new molecularly imprinted polymer. Anal. Chim. Acta 2008, 620:73-81.
13. Heberer T., Feldmann D. Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents-modeling versus measurements. J. Hazard. Mater. 2005, 122:211-218.
14. IMS Health Biopharma Market Forecasts and Trends 2014, (retrieved 10.01.14). http://www.imshealth.com/portal/site/imshealth.
15. Aater Laak T.L., van der M., Houtman C.J., Stoks P.G., van Wezel A.P. Relating environmental concentrations of pharmaceuticals to consumption: a mass balance approach for the river Rhine. Environ. Int. 2010, 36:403-409.
16. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72:1118-1123.
17. Kreuzinger N., Clara M., Strenn B., Kroiss H. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci. Technol. 2004, 50:149-156.
18. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68:141-150.
19. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
20. Metcalfe C.D., Koenig B.G., Bennie D.T., Servos M., Ternes T.A., Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ. Toxicol. Chem. 2003, 22:2872-2880.
21. Brun G.L., Bernier M., Losier R., Doe K., Jackman P., Lee H.-B. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ. Toxicol. Chem. 2006, 25:2163-2176.
22. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
23. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
24. Wiegel S., Aulinger A., Brockmeyer R., Harms H., Loffler J., Reincke H., Schmidt R., Stachel B., von Tumpling W., Wanke A. Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 2004, 57:107-126.
25. Yu J.T., Bouwer E.J., Coelhan M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric. Water Manage. 2006, 86:72-80.
26. Zhou J.L., Zhang Z.L., Banks E., Grover D., Jiang J.Q. Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J. Hazard. Mater. 2009, 166:655-661.
27. Xue W.C., Wu C.Y., Xiao K., Huang X., Zhou H.D., Tsuno H., Tanaka H. Elimination and fate of selected microorganic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation. Water Res. 2010, 44:5999-6010.
28. Martín J., Camacho-Munoz D., Santos J.L., Aparicio I., Alonso E. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. J. Hazard. Mater. 2012, 239:40-47.
29. Topuz E., Sari S., Özdemir G., Aydin E., Pehlivanoglu-Mantas E., OkutmanTas D. Optimization of ultrasonic assisted diclofenac extraction from wastewater treatment plant sludge. IWA Micropol & Ecohazard 2013.
30. APHA Standard Methods for the Examination of Water and Wastewater 2005, American Water Works Association/Water Environment Federation, Washington, DC. 21st ed.
31. Kraigher B., Mandic-Mulec I. Nitrification activity and community structure of nitrite-oxidizing bacteria in the bioreactors operated with addition of pharmaceuticals. J. Hazard. Mater. 2011, 188:78-84.
32. Matamoros V., Arias C., Brix H., Bayona J.M. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical flow constructed wetland and a sand filter. Environ. Sci. Technol. 2007, 41:8171-8177.
33. Graaff M.S., Vieno N.M., Kujawa-Roeleveld K., Zeeman G., Temmink H., Buisman C.J.N. Fate of hormones and pharmaceuticals during combined anaerobic treatment and nitrogen removal by partial nitritation-anammox in vacuum collected black water. Water Res. 2011, 45:375-383.
34. Matsuo H., Sakamoto H., Arizono K., Shinohara R. Behavior of pharmaceuticals in wastewater treatment plant in Japan. Bull. Environ. Contam. Toxicol. 2011, 87:31-35.
35. Salgado R., Marques R., Noronha J.P., Carvalho G., Oehmen A., Reis M.A.M. Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. Environ. Sci. Pollut. Res. 2012, 19:1818-1827.
36. Jelic A., Francesco Fatone F., Fabio S.D., Petrovic M., Cecchi F., Barcelo D. Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment. Sci. Total Environ. 2012, 433:352-361.
37. Soufan M., Deborde M., Legube B. Aqueous chlorination of diclofenac: kinetic study and transformation products identification. Water Res. 2012, 46:3377-3386.
38. Sein M.M., Schmidt T.C., Golloch A., von Sonntag C. Oxidation of some typical wastewater contaminants (tributyltin, clarithromycin, metoprolol and diclofenac) by ozone. Water Sci. Technol. 2009, 59:1479-1485.
39. Hey G., Grabic R., Ledin A., La Cour Jansen J., Andersen H.R. Oxidation of pharmaceuticals by chlorine dioxide in biologically treated wastewater. Chem. Eng. J. 2012, 185:236-242.
40. Wang Y., Liu H., Liu G., Xie Y. Oxidation of diclofenac by aqueous chlorine dioxide: identification of major disinfection byproducts and toxicity evaluation. Sci. Total Environ. 2014, 473-474:437-445.
41. Perez S., Barcelo D. First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QQLIT-MS and QQTOF-MS. Anal. Chem. 2008, 80:8135-8145.
42. Kosjek T., Heath E., Kompare B. Removal of pharmaceutical residues in a pilot wastewater treatment plant. Anal. Bioanal. Chem. 2007, 387:1379-1387.
43. Kosjek T., Heath E., Petrovic M., Barcelo D. Mass spectrometry for identifying pharmaceutical biotransformation products in the environment. Trends Anal. Chem. 2007, 26:1076-1085.
44. Santos J.L., Aparicio I., Callejón M., Alonso E. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J. Hazard. Mater. 2009, 164:1509-1516.
45. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res. 2005, 39:1761-1772.
46. Johnson A.C. Natural variations in flow are critical in determining concentrations of point source contaminants in rivers: an estrogen example. Environ. Sci. Technol. 2010, 44:7865-7870.
47. Sui Q., Huang J., Deng S., Chen W., Yu G. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes. Environ. Sci. Technol. 2011, 45:3341-3348.
48. Coutu S., Rossi L., Barry D.A., Rudaz S., Vernaz N. Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals. PLOS One 2013, 8:1-8.
49. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39:3981-3989.
50. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005, 39:3139-3152.
51. Maskaoui K., Zhou J.L. Colloids as a sink for certain pharmaceuticals in the aquatic environment. Environ. Sci. Pollut. Res. 2010, 17:898-907.
52. Tran N.H., Urase T., Kusakabe O. The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds. J. Hazard. Mater. 2009, 171:1051-1057.